Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

Yuuki Ohara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9171-4724; OpenAlex author ID A5034007772. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper · 2024: 4 papers · 2025: none · 2026: 2 papers

Papers 9

  1. Basal Marker ΔNp63α Is Enriched in Pancreatic Cancer Metastases but Not in Primary Tumors Post-Chemotherapy. First author DOI 10.1002/cam4.72322↗
  2. Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Insights into tumor heterogeneity and clini… Co-author DOI 10.1016/j.pharmthera.2025.108946↗
  3. ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer. Co-author DOI 10.1002/ijc.34960↗
  4. LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism. Co-author DOI 10.1093/carcin/bgae011↗
  5. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways. Co-author DOI 10.1093/carcin/bgae025↗
  6. ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. First author DOI 10.1093/carcin/bgae056↗
  7. SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2023.113434↗
  8. The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer. Co-author DOI 10.1016/j.trecan.2022.03.004↗
  9. Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients. Co-author DOI 10.1093/carcin/bgac092↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. S. Perwez Hussain · 8 shared papers, 2022–2026 · strength 1.67
  2. Paloma Moreno · 5 shared papers, 2023–2026 · strength 1.10
  3. Nader N Hanna · 6 shared papers, 2022–2024 · strength 1.03
  4. Jochen Gaedcke · 6 shared papers, 2022–2024 · strength 1.03
  5. Azadeh Azizian · 6 shared papers, 2022–2024 · strength 1.03
  6. Michael B. Ghadimi · 5 shared papers, 2023–2024 · strength 0.90
  7. S. S. Yang · 3 shared papers, 2024 · strength 0.56
  8. Shouhui Yang · 3 shared papers, 2022–2024 · strength 0.47
  9. Daniel H. Ryan · 1 shared paper, 2026 · strength 0.33
  10. Christine Alewine · 1 shared paper, 2026 · strength 0.33
  11. Lin Zhang · 1 shared paper, 2024 · strength 0.18
  12. Jianjun Gao · 1 shared paper, 2024 · strength 0.18
  13. Subrata Sen · 1 shared paper, 2024 · strength 0.18
  14. Nagireddy Putluri · 1 shared paper, 2024 · strength 0.18
  15. Β. Michael Ghadimi · 1 shared paper, 2022 · strength 0.13
  16. Lin Zhang · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.